Equillium, Inc. (EQ)
EQ moved a median of 0.00% 30 minutes after news, and -0.61% by the close. How EQ actually reacts to news — the realized, point-in-time move the market made, measured across 233 labeled events over the last three years with zero look-ahead.
EQ’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 40% | 214 |
| 30-min | 0.00% | 51% | 226 |
| 60-min | -0.12% | 45% | 233 |
| to close | -0.61% | 43% | 232 |
| Middle 50% of EQ reactions | -4.13% to +1.72% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 233 |
Half of all Equillium, Inc. news events land between -4.13% and +1.72% at 30 minutes.
Reaction stats as of 2026-08-31. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How EQ reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 17 | -1.67% | 29% | -4.48% |
| Rating reiterations | 18 | 0.00% | 44% | -1.25% |
Last 3 years, pulled 2026-08-31. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how EQ ranks against every other measured name →
That’s how EQ usually reacts — get an email when it moves on news →Email me when EQ moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to EQ's baseline. Nothing else.
Recent EQ events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Equillium to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +2.27% | +2.27% | |
| Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights | Press release | GlobeNewswire | -1.97% | +16.26% | |
| Form 10-Q Equillium, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.97% | +16.26% | |
| Form 8-K Equillium, Inc. For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | -1.97% | +16.26% | |
| Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +3.58% | +11.47% | |
| Form 8-K Equillium, Inc. For: May 28 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +6.21% | |
| Equillium to Participate in the 2026 Jefferies Global Healthcare Conference | Press release | GlobeNewswire | -5.41% | -2.03% | |
| Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis | Press release | GlobeNewswire | -1.48% | +8.87% | |
| Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights | Press release | GlobeNewswire | +1.12% | +15.63% | |
| Form 10-Q Equillium, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +1.12% | +15.63% | |
| Form 8-K Equillium, Inc. For: May 13 | SEC filing · Form 8-K | SEC EDGAR | +1.12% | +15.63% | |
| Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | -0.96% | +0.48% | |
| Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event | Press release | GlobeNewswire | -1.51% | +8.04% | |
| Form EFFECT Equillium, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.48% | -0.48% | |
| Form ARS Equillium, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +2.62% | +7.33% | |
| Form DEF 14A Equillium, Inc. For: May 28 | SEC filing · Form DEF | SEC EDGAR | +2.62% | +7.33% | |
| Form DEFA14A Equillium, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +2.62% | +7.33% | |
| Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists | Press release | GlobeNewswire | +3.02% | -7.22% | |
| Form S-3 Equillium, Inc. | SEC filing · Form S-3 | SEC EDGAR | +3.02% | -7.22% | |
| Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +4.06% | +2.03% | |
| Form PRE 14A Equillium, Inc. For: May 28 | SEC filing · Form PRE | SEC EDGAR | +7.10% | +13.64% | |
| Form EFFECT Equillium, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +1.00% | +3.52% | |
| Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights | Press release | GlobeNewswire | +1.00% | +3.52% | |
| Form 10-K Equillium, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +1.00% | +3.52% | |
| Form 8-K Equillium, Inc. For: Mar 25 | SEC filing · Form 8-K | SEC EDGAR | +1.00% | +3.52% | |
| Form S-8 Equillium, Inc. | SEC filing · Form S-8 | SEC EDGAR | +1.00% | +3.52% | |
| Equillium to Participate in the 38th Annual Roth Conference | Press release | GlobeNewswire | +1.40% | -0.47% | |
| Equillium Announces $35 Million Financing with RA Capital Management | Press release | GlobeNewswire | -1.24% | +1.65% | |
| Form 8-K Equillium, Inc. For: Mar 11 | SEC filing · Form 8-K | SEC EDGAR | -1.24% | +1.65% | |
| Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference | Press release | GlobeNewswire | -3.09% | -5.67% | |
| Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +2.65% | +0.00% | |
| Equillium to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | -3.42% | -7.69% | |
| Equillium to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | -1.32% | -4.64% | |
| Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | -1.32% | -4.64% | |
| Cipla's flagship respiratory initiative Breathefree broadens its footprint in the UAE | Press release | PR Newswire | +1.42% | -2.84% | |
| Form 8-K/A Equillium, Inc. For: Sep 30 | SEC filing · Form 8-K | SEC EDGAR | +1.42% | -2.84% | |
| Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025 | Press release | GlobeNewswire | -2.59% | -5.84% | |
| Equillium Announces Leadership and Corporate Updates | Press release | GlobeNewswire | -0.64% | -4.49% | |
| Form 8-K Equillium, Inc. For: Sep 30 | SEC filing · Form 8-K | SEC EDGAR | -0.64% | -4.49% | |
| Form 8-K Equillium, Inc. For: Sep 19 | SEC filing · Form 8-K | SEC EDGAR | -0.70% | +1.40% | |
| Form EFFECT Equillium, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +3.23% | -2.67% | |
| Form S-3 Equillium, Inc. | SEC filing · Form S-3 | SEC EDGAR | +2.73% | +0.55% | |
| Form S-8 Equillium, Inc. | SEC filing · Form S-8 | SEC EDGAR | +2.73% | +0.55% | |
| Form 8-K Equillium, Inc. For: Aug 29 | SEC filing · Form 8-K | SEC EDGAR | +2.02% | +10.40% | |
| Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Press release | Business Wire | -1.08% | -5.41% | |
| Equillium to Participate in the Cantor Global Healthcare Conference 2025 | Press release | Business Wire | -3.60% | +2.99% | |
| Form 10-Q Equillium, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.01% | +14.00% | |
| Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic | Press release | Business Wire | -8.26% | -18.73% | |
| Form 8-K Equillium, Inc. For: Aug 10 | SEC filing · Form 8-K | SEC EDGAR | -8.26% | -18.73% | |
| Equillium Announces Strategic Expansion of Cryptocurrency Treasury Reserve Strategy | Press release | Business Wire | +3.51% | -10.45% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the EQ section they belong to.
Where else EQ is measured.
EQ earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE (TRPX) | 234 | -1.05% | 31% |
| Dyadic International, Inc. (DYAI) | 233 | 0.00% | 46% |
| Eton Pharmaceuticals, Inc. (ETON) | 233 | -0.34% | 40% |
| OrthoPediatrics Corp. (KIDS) | 232 | +0.03% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Equillium, Inc.'s median reaction calculated?
Every labeled EQ news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 233 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of EQ's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-31.
Does EQ's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.